---
figid: PMC4993159__nihms-802945-f0002
figtitle: Hepcidin Regulation in the Anemia of Inflammation
organisms:
- NA
pmcid: PMC4993159
filename: nihms-802945-f0002.jpg
figlink: /pmc/articles/PMC4993159/figure/F2/
number: F2
caption: 'Agents targeting the BMP/SMAD pathway include: LDN-193189 inhibiting BMP
  type I receptor activity; soluble hemojuvelin fusion protein (sHJV), heparin, and
  BMP6 antibody (Ab) sequestering BMP ligands; hemojuvelin (HJV) Ab neutralizing HJV
  function; and follistatin-315 sequestering Activin B. Agents inhibiting IL6-STAT3
  signaling include: Siltuximab neutralizing IL6, hydrogen sulfide suppressing IL6
  and STAT3, and Tocilizumab targeting the IL6 receptor (IL6R). Agents targeting hepcidin
  and ferroportin (FPN) include: hepcidin Ab, anticalins (PRS-080) and spiegelmers
  (NOX-H94) inhibiting hepcidin protein; hepcidin antisense oligonucleotides (ASO)
  targeting hepcidin mRNA; and FPN Ab (LY2928057) targeting the hepcidin binding site
  on FPN.'
papertitle: Hepcidin Regulation in the Anemia of Inflammation.
reftext: Chia-Yu Wang, et al. Curr Opin Hematol. ;23(3):189-197.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9477398
figid_alias: PMC4993159__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4993159__F2
ndex: 57094e38-def6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4993159__nihms-802945-f0002.html
  '@type': Dataset
  description: 'Agents targeting the BMP/SMAD pathway include: LDN-193189 inhibiting
    BMP type I receptor activity; soluble hemojuvelin fusion protein (sHJV), heparin,
    and BMP6 antibody (Ab) sequestering BMP ligands; hemojuvelin (HJV) Ab neutralizing
    HJV function; and follistatin-315 sequestering Activin B. Agents inhibiting IL6-STAT3
    signaling include: Siltuximab neutralizing IL6, hydrogen sulfide suppressing IL6
    and STAT3, and Tocilizumab targeting the IL6 receptor (IL6R). Agents targeting
    hepcidin and ferroportin (FPN) include: hepcidin Ab, anticalins (PRS-080) and
    spiegelmers (NOX-H94) inhibiting hepcidin protein; hepcidin antisense oligonucleotides
    (ASO) targeting hepcidin mRNA; and FPN Ab (LY2928057) targeting the hepcidin binding
    site on FPN.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - HJV
  - APP
  - SUCLA2
  - INHBA
  - INHBB
  - IL6
  - BMPR2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT3
  - SMN1
  - HAMP
  - SLC40A1
  - LDN-193189
---
